Akums Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
420.40
0.1 (0.02%)
BSENSE

Dec 05

BSE+NSE Vol: 36.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
30.62
28.61
28.61
14.31
1.30
1.30
Share Warrants & Outstandings
Total Reserve
3,016.39
680.88
688.58
607.67
883.55
721.10
Shareholder's Funds
3,047.01
709.50
717.19
621.98
884.85
722.40
Minority Interest
16.60
10.99
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
78.30
115.50
13.33
1.16
9.85
Secured Loans
0.00
78.30
115.50
13.33
0.00
9.85
Unsecured Loans
0.00
0.00
0.00
0.00
1.16
0.00
Deferred Tax Assets / Liabilities
-189.45
-110.91
-6.22
20.45
26.57
33.16
Other Long Term Liabilities
101.57
1463.85
1110.56
1094.9
636.91
524.21
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
35.90
31.02
26.23
23.93
20.44
18.71
Total Non-Current Liabilities
-51.98
1,462.26
1,246.07
1,152.61
685.08
585.93
Current Liabilities
Trade Payables
642.78
532.13
567.14
589.67
341.41
423.32
Other Current Liabilities
180.10
208.56
231.01
279.21
95.87
114.31
Short Term Borrowings
13.65
413.26
421.48
344.62
86.05
129.98
Short Term Provisions
57.21
56.60
45.94
58.92
56.62
62.37
Total Current Liabilities
893.75
1,210.55
1,265.57
1,272.42
579.95
729.98
Total Liabilities
3,905.38
3,393.30
3,235.01
3,050.20
2,152.17
2,036.80
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
2,054.53
1,752.84
1,540.87
1,428.76
1,245.09
992.40
Less: Accumulated Depreciation
818.64
679.27
569.92
489.28
411.29
348.02
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
1,235.88
1,073.57
970.95
939.48
833.80
644.38
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
159.62
195.13
102.99
30.82
87.20
56.60
Intangible assets under development
3.17
0.28
0.16
0.25
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.14
0.14
0.14
0.39
0.53
0.56
Long Term Loans & Advances
61.56
56.52
96.45
88.80
57.50
68.61
Other Non Current Assets
8.91
9.58
59.07
45.34
15.74
16.81
Total Non-Current Assets
1,630.77
1,452.42
1,356.14
1,186.13
994.77
786.95
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
19.01
5.84
Inventories
680.93
630.42
729.79
722.45
429.86
398.32
Sundry Debtors
770.30
833.81
845.09
884.31
531.40
581.54
Cash and Bank
576.45
277.05
149.99
102.85
67.87
147.36
Other Current Assets
61.33
31.97
40.32
29.40
26.54
24.08
Short Term Loans and Advances
185.60
167.63
113.68
125.06
82.73
92.71
Total Current Assets
2,274.61
1,940.88
1,878.87
1,864.06
1,157.40
1,249.85
Net Current Assets (Including Current Investments)
1,380.86
730.33
613.30
591.64
577.45
519.87
Total Current Assets Excluding Current Investments
2,274.61
1,940.88
1,878.87
1,864.06
1,138.40
1,244.00
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
3,905.38
3,393.30
3,235.01
3,050.20
2,152.17
2,036.80
Contingent Liabilities
91.55
88.62
81.54
97.51
22.49
0.00
Total Debt
0.00
491.56
536.97
357.95
87.21
139.83
Book Value per share (adjusted)
199.01
49.59
50.13
43.475
1360.256
50.4946363636364
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -97.22% vs -8.46% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -93.06% vs 31.81% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 9.99% vs 18.14% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 17.19% vs 3.30% in Mar 2024

Compare Balance Sheet Results of Akums Drugs
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
30.62
16.28
14.34
88.08%
Share Warrants & Outstandings
Total Reserve
3,016.39
2,264.80
751.59
33.19%
Shareholder's Funds
3,047.01
2,281.08
765.93
33.58%
Minority Interest
16.60
0.00
16.60
0.00%
Long-Term Borrowings
0.00
0.11
-0.11
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.11
-0.11
-100.00%
Deferred Tax Assets / Liabilities
-189.45
22.90
-212.35
-927.29%
Other Long Term Liabilities
101.57
12.01
89.56
745.71%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
35.90
36.07
-0.17
-0.47%
Total Non-Current Liabilities
-51.98
71.08
-123.06
-173.13%
Current Liabilities
Trade Payables
642.78
205.15
437.63
213.32%
Other Current Liabilities
180.10
132.46
47.64
35.97%
Short Term Borrowings
13.65
0.00
13.65
0.00%
Short Term Provisions
57.21
24.03
33.18
138.08%
Total Current Liabilities
893.75
361.64
532.11
147.14%
Total Liabilities
3,905.38
2,713.80
1,191.58
43.91%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2,054.53
1,122.60
931.93
83.02%
Less: Accumulated Depreciation
818.64
299.99
518.65
172.89%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1,235.88
822.60
413.28
50.24%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
159.62
136.09
23.53
17.29%
Intangible assets under development
3.17
0.75
2.42
322.67%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.14
543.17
-543.03
-99.97%
Long Term Loans & Advances
61.56
92.21
-30.65
-33.24%
Other Non Current Assets
8.91
1.32
7.59
575.00%
Total Non-Current Assets
1,630.77
1,625.09
5.68
0.35%
Current Assets Loans & Advances
Current Investments
0.00
484.65
-484.65
-100.00%
Inventories
680.93
375.03
305.90
81.57%
Sundry Debtors
770.30
108.85
661.45
607.67%
Cash and Bank
576.45
52.77
523.68
992.38%
Other Current Assets
61.33
11.67
49.66
425.54%
Short Term Loans and Advances
185.60
55.75
129.85
232.91%
Total Current Assets
2,274.61
1,088.72
1,185.89
108.93%
Net Current Assets (Including Current Investments)
1,380.86
727.08
653.78
89.92%
Total Current Assets Excluding Current Investments
2,274.61
604.06
1,670.55
276.55%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
3,905.38
2,713.80
1,191.58
43.91%
Contingent Liabilities
91.55
107.54
-15.99
-14.87%
Total Debt
0.00
0.11
-0.11
-100.00%
Book Value per share (adjusted)
199.01
140.11
58.90
42.04%
Annual - Borrowings
Borrowings 13.65 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -97.22% vs -8.46% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 101.57 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -93.06% vs 31.81% in Mar 2024

Annual - Fixed Assets
Fixed Assets 1,395.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.99% vs 18.14% in Mar 2024

Annual - Investments
Investments 0.14 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 2,274.61 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.19% vs 3.30% in Mar 2024